Found 7 matching trials
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
PHASE2The overall purpose of this research study is to find a better way to treat...
Location
H. Lee Moffitt Cancer Center and Research Institute
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
PHASE3The purpose of this clinical trial is to evaluate the benefit of the immuno...
Location
GSK Investigational Site
Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
EARLY_PHASE1The goals of this study are to 1) assess the safety of recombinant MAGE-A3 ...
Location
University of Virginia
Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
PHASE2The purpose of this clinical trial was to demonstrate the benefit of the im...
Location
Faculty teaching Hospital in Plzen
High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
PHASE2The goal of this clinical research study is to learn if high-dose interleuk...
Location
University of Texas MD Anderson Cancer Center
MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
PHASE1This was an open-label, single-arm, pilot study of the recombinant MAGE-A3 ...
Location
New York University School of Medicine
BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients
PHASE1In this study, the investigators would like to assess how intravesical BCG ...
Location
Centre Hospitalier Universitaire Vaudois (CHUV)